Skip to content

Comparing 2 medications in management of necrotic pulp in primary molars

Evaluation of Postoperative Pain after Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201701001868213
Enrollment
92
Registered
2016-11-14
Start date
2016-11-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

necrotic primary molars

Interventions

3-mix-tatin
calcium hydroxide iodoform

Sponsors

department of peadiatric dentistry, cairo UNIVERSITY
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ¿ Children age range from 5-8 years. ¿ Children free from any systemic diseases or medical problems. ¿ Primary molar with necrotic pulp, with pain, gingival abscess, fistula openings, or clinical mobility not exceeding grade two. ¿ Radiographic evidence of non-perforating internal resorption, external resorption not exceeding 1\3 of the root, furcation or periapical radiolucency.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ¿ Non-restorable molars or beyond repair, for example: decay reaches to bifurcation, a hard gingival margin cannot be established or infection cannot be eradicated by other mean(Balaji, 2007). ¿ Patient with known allergy to any type of antibiotics or anti-hyperlipidemia drugs. ¿ Patient on antibiotic therapy over the last 2 weeks. ¿ Patient with facial cellulitis or lymphadenopathy ¿ Lack of patient/parent compliance and cooperation. ¿ Refusal of participation or failure to obtain an informed consent

Design outcomes

Primary

MeasureTime frame
post operative pain

Secondary

MeasureTime frame
mobility ;sinus and fistula

Countries

Egypt

Contacts

Public Contactraadwa yousef
crazy_dr4444@yahoo.com010003590167

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026